The presence of anticitrullinated peptide antibodies (ACPA) is one of the factors that not only precedes the onset of RA, but also leads to the more aggressive course of the disease including joint damage, increased disease activity, and worse functional outcomes [2]. Here, PRTN3 is linked to rheumatoid arthritis.